These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10606784)

  • 1. Enhanced efficacy by percutaneous absorption of piroxicam from the poloxamer gel in rats.
    Shin S; Cho C; Oh I
    Int J Pharm; 2000 Jan; 193(2):213-8. PubMed ID: 10606784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of non-ionic surfactants as permeation enhancers towards piroxicam from the poloxamer gel through rat skins.
    Shin SC; Cho CW; Oh IJ
    Int J Pharm; 2001 Jul; 222(2):199-203. PubMed ID: 11427350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing effects of fatty acids on piroxicam permeation through rat skins.
    Shin SC; Shin EY; Cho CW
    Drug Dev Ind Pharm; 2000 May; 26(5):563-6. PubMed ID: 10789070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeation of piroxicam from the poloxamer gels.
    Shin SC; Cho CW; Choi HK
    Drug Dev Ind Pharm; 1999 Mar; 25(3):273-8. PubMed ID: 10071819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm.
    Okuyama H; Ikeda Y; Kasai S; Imamori K; Takayama K; Nagai T
    Int J Pharm; 1999 Sep; 186(2):141-8. PubMed ID: 10486432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam.
    Xuan JJ; Balakrishnan P; Oh DH; Yeo WH; Park SM; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):317-23. PubMed ID: 20573569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application.
    Santoyo S; Ygartua P
    Eur J Pharm Biopharm; 2000 Sep; 50(2):245-50. PubMed ID: 10962234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile and adverse gastric effect of zinc-piroxicam in rats.
    Tagliati CA; Kimura E; Nothenberg MS; Santos SR; Oga S
    Gen Pharmacol; 1999 Jul; 33(1):67-71. PubMed ID: 10428018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of analgesic and anti-inflammatory activity of meloxicam gel with diclofenac and piroxicam gels in animal models: pharmacokinetic parameters after topical application.
    Gupta SK; Bansal P; Bhardwaj RK; Jaiswal J; Velpandian T
    Skin Pharmacol Appl Skin Physiol; 2002; 15(2):105-11. PubMed ID: 11867967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen.
    Park ES; Chang SY; Hahn M; Chi SC
    Int J Pharm; 2000 Nov; 209(1-2):109-19. PubMed ID: 11084251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced rectal bioavailability of ibuprofen in rats by poloxamer 188 and menthol.
    Yong CS; Yang CH; Rhee JD; Lee BJ; Kim DC; Kim DD; Kim CK; Choi JS; Choi HG
    Int J Pharm; 2004 Jan; 269(1):169-76. PubMed ID: 14698588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nonionic surfactants on the percutaneous absorption tenoxicam.
    Endo M; Yamamoto T; Ijuin T
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):865-7. PubMed ID: 8681419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro percutaneous absorption of piroxicam through synthetic membranes and abdominal rat skin.
    Santoyo S; Arellano A; Ygartua P; Martín C
    Pharm Acta Helv; 1996 Jul; 71(2):141-6. PubMed ID: 8810580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethyl cellulose nanoparticles as a platform to decrease ulcerogenic potential of piroxicam: formulation and in vitro/in vivo evaluation.
    El-Habashy SE; Allam AN; El-Kamel AH
    Int J Nanomedicine; 2016; 11():2369-80. PubMed ID: 27307735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of piroxicam absorption by oral mucosa.
    Diez-Ortego I; Cruz M; Largo R; Navarro A; Palacios I; Solans A; Sanchez-Pernaute O; Egido J; Herrero-Beaumont G
    Arzneimittelforschung; 2002; 52(5):385-7. PubMed ID: 12087924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transbuccal permeation, anti-inflammatory activity and clinical efficacy of piroxicam formulated in different gels.
    Attia MA; El-Gibaly I; Shaltout SE; Fetih GN
    Int J Pharm; 2004 May; 276(1-2):11-28. PubMed ID: 15113610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced local anesthetic action of mepivacaine from the bioadhesive gels.
    Cho CW; Choi JS; Shin SC
    Pak J Pharm Sci; 2011 Jan; 24(1):87-93. PubMed ID: 21190925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biowaiver monographs for immediate release solid oral dosage forms: piroxicam.
    Shohin IE; Kulinich JI; Ramenskaya GV; Abrahamsson B; Kopp S; Langguth P; Polli JE; Shah VP; Groot DW; Barends DM; Dressman JB
    J Pharm Sci; 2014 Feb; 103(2):367-77. PubMed ID: 24301077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.